Literature DB >> 22899241

Clinical utility of 13C-liver-function breath tests for assessment of hepatic function.

P Afolabi1, M Wright, S A Wootton, A A Jackson.   

Abstract

13C-Liver-function breath tests have been used in clinical diagnostics and, to a limited extent, to investigate hepatic function. From a practical perspective, tests such as the 13C-aminopyrine and 13C-methacetin breath tests are simple to administer, safe, and relatively inexpensive to perform. Surprisingly, they have not entered the mainstream of clinical practice, because they are perceived to lack the specificity and adequate precision needed to give accurate results in real time. The dynamic nature of 13C-liver-function breath tests, their possible versatility in terms of assessing a range of different liver functions, and the ease with which they can be repeated to follow relative changes in liver function with time, all imply the potential for wider clinical application. Therefore, there is a need for these tests to be critically evaluated and their potential clinical application be tested systematically against defined objectives. We describe refinements in the methodology of the tests and propose several situations in which currently reliable methods for assessment of liver function do not exist and where 13C-liver-function breath tests might be of use. We propose that use has been constrained by practical methodological considerations which could be addressed to offer tests better suited to routine application in the out-patient or community setting.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899241     DOI: 10.1007/s10620-012-2340-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  MAMMALIAN GALACTOKINASE. DEVELOPMENTAL AND ADAPTIVE CHARACTERISTICS IN THE RAT LIVER.

Authors:  P CUATRECASAS; S SEGAL
Journal:  J Biol Chem       Date:  1965-06       Impact factor: 5.157

Review 2.  13C-breath tests for clinical investigation of liver mitochondrial function.

Authors:  Ignazio Grattagliano; Bernhard H Lauterburg; Giuseppe Palasciano; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2010-07-01       Impact factor: 4.686

3.  13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate.

Authors:  Matthias Banasch; Oliver Goetze; Ivo Hollborn; Bettina Hochdorfer; Kerem Bulut; Renate Schlottmann; Dirk Hagemann; Norbert H Brockmeyer; Wolfgang E Schmidt; Frank Schmitz
Journal:  J Acquir Immune Defic Syndr       Date:  2005-10-01       Impact factor: 3.731

4.  13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.

Authors:  Julia Holtmeier; Maria Leuschner; Arne Schneider; Ulrich Leuschner; Wolfgang F Caspary; Barbara Braden
Journal:  Scand J Gastroenterol       Date:  2006-11       Impact factor: 2.423

5.  Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B.

Authors:  P Honkoop; R A de Man; H R Scholte; P E Zondervan; J W Van Den Berg; L H Rademakers; S W Schalm
Journal:  Hepatology       Date:  1997-07       Impact factor: 17.425

6.  Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid.

Authors:  P A Michaletz; L Cap; E Alpert; B H Lauterburg
Journal:  Hepatology       Date:  1989-11       Impact factor: 17.425

7.  Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis.

Authors:  B H Lauterburg; D Liang; F A Schwarzenbach; K J Breen
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

8.  Mitochondrial function reflected by the decarboxylation of [13C]ketoisocaproate is impaired in alcoholics.

Authors:  A Witschi; S Mossi; B Meyer; E Junker; B H Lauterburg
Journal:  Alcohol Clin Exp Res       Date:  1994-08       Impact factor: 3.455

Review 9.  13C-breath tests in hepatology (cytosolic liver function).

Authors:  F Perri; R M L Marras; R Ricciardi; M Quitadamo; A Andriulli
Journal:  Eur Rev Med Pharmacol Sci       Date:  2004 Jan-Feb       Impact factor: 3.507

Review 10.  13C-breath tests in the study of mitochondrial liver function.

Authors:  M Candelli; I A Cazzato; M A Zocco; E C Nista; L Fini; A Armuzzi; V Camise; M Santoro; L Miele; A Grieco; G Gasbarrini; A Gasbarrini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2004 Jan-Feb       Impact factor: 3.507

View more
  14 in total

Review 1.  Alternative Sampling Strategies for Cytochrome P450 Phenotyping.

Authors:  Pieter M M De Kesel; Willy E Lambert; Christophe P Stove
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

2.  How far is the development of 13C-liver-function breath tests?

Authors:  Martin Stockmann; Johan Friso Lock
Journal:  Dig Dis Sci       Date:  2013-04-06       Impact factor: 3.199

3.  Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test.

Authors:  Michael Haimerl; Irene Fuhrmann; Stefanie Poelsterl; Claudia Fellner; Marcel D Nickel; Kilian Weigand; Marc H Dahlke; Niklas Verloh; Christian Stroszczynski; Philipp Wiggermann
Journal:  Eur Radiol       Date:  2018-03-12       Impact factor: 5.315

Review 4.  Noninvasive assessment of liver function.

Authors:  Steve Helmke; Jordi Colmenero; Gregory T Everson
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

Review 5.  Preoperative liver function assessments to estimate the prognosis and safety of liver resections.

Authors:  Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Thomas T Hui; Koichi Hirata
Journal:  Surg Today       Date:  2013-03-09       Impact factor: 2.549

Review 6.  Breath tests to phenotype drug disposition in oncology.

Authors:  Frans L Opdam; Anil S Modak; Hans Gelderblom; Henk-Jan Guchelaar
Journal:  Clin Pharmacokinet       Date:  2013-11       Impact factor: 6.447

7.  Relationship between 13C-aminopyrine breath test and the MELD score and its long-term prognostic use in patients with cirrhosis.

Authors:  Edoardo G Giannini; Vincenzo Savarino
Journal:  Dig Dis Sci       Date:  2013-07-02       Impact factor: 3.199

Review 8.  European guideline on indications, performance and clinical impact of 13 C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC.

Authors:  Jutta Keller; Heinz F Hammer; Paul R Afolabi; Marc Benninga; Osvaldo Borrelli; Enrique Dominguez-Munoz; Dan Dumitrascu; Oliver Goetze; Stephan L Haas; Bruno Hauser; Daniel Pohl; Silvia Salvatore; Marc Sonyi; Nikhil Thapar; Kristin Verbeke; Mark R Fox
Journal:  United European Gastroenterol J       Date:  2021-06-14       Impact factor: 4.623

9.  Phase-1 evaluation of 13C-liver function breath tests.

Authors:  Anna Kasicka-Jonderko; Krzysztof Jonderko
Journal:  Dig Dis Sci       Date:  2013-02       Impact factor: 3.199

10.  Assessment of hepatic detoxification activity: proposal of an improved variant of the (13)c-methacetin breath test.

Authors:  Hermann-Georg Holzhütter; Johan Friso Lock; Pouria Taheri; Sascha Bulik; Andrean Goede; Martin Stockmann
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.